A new study at the Osaka Women’s and Children’s Hospital in Japan has shown that the EMMA Capnograph device from medical technology company Masimo could be effective for monitoring preterm infants, or neonates, who are on mechanical ventilation.

The portable EMMA device is designed for capnography in patients of any age.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

It does not need routine calibration and delivers precise measurements of end-tidal carbon dioxide (EtCO₂) as well as respiration rate and continuous EtCO₂ waveforms in under 15 seconds, the company said.

Maintenance of a suitable range of partial pressure of arterial carbon dioxide (PaCO₂) in preterm infants is considered vital, particularly in those on mechanical ventilation in the neonatal intensive care unit (NICU).

In the latest study, researchers assessed if non-invasive monitoring of EtCO₂ with the EMMA device could potentially aid clinicians in maintaining PaCO₂ levels for neonates in the delivery room.

The study involved 40 neonates needing intubation in the delivery room.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The PaCO₂ value in these 40 infants at admission to the NICU or two hours post-birth was compared to that of 43 infants with no EMMA monitoring.

For the study, the researchers determined ‘appropriate’ PaCO₂ as 35-60mmHg, measured with a blood gas analyser.

Data revealed that the proportion of neonates with appropriate PaCO₂ was higher in the EMMA group as compared to the control group.

When categorised based on birth, smaller neonates had no significant difference in the proportion of infants with appropriate PaCO₂ between groups.

However, in the larger cohort, the appropriate PaCO₂ rate was significantly greater in the EMMA group, at 93% versus 44%.

In a statement, Masimo said: “The study authors concluded that EMMA facilitated the maintenance of an appropriate PaCO₂ for mechanically ventilated preterm infants, especially infants with birth weight ≥ 1000 g, in the delivery room.

“They noted that the main strength of their study was that they collected intervention data prospectively and showed the feasibility of using a portable capnometer during resuscitation of intubated preterm infants – the first study of its kind.”

In July, Masimo reported that two parameters, patient state index (PSi) and suppression ratio (SR), provided by Masimo SedLine brain function monitoring had greater predictability for death 180 days after cardiac arrest, in a study.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact